We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.1B
AUM Growth
+$2.17B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
10.47%
Top 10 Holdings %
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$177M |
| 2 |
Lowe's Companies
LOW
|
+$108M |
| 3 |
STJ
St Jude Medical
STJ
|
+$95.4M |
| 4 |
Newell Brands
NWL
|
+$88.6M |
| 5 |
Constellation Brands
STZ
|
+$87.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$136M |
| 2 |
UnitedHealth
UNH
|
+$99.3M |
| 3 |
PayPal
PYPL
|
+$85.4M |
| 4 |
Starbucks
SBUX
|
+$78.1M |
| 5 |
Cigna
CI
|
+$64.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.63% |
| 2 | Consumer Discretionary | 12.48% |
| 3 | Communication Services | 12.09% |
| 4 | Technology | 9.72% |
| 5 | Industrials | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Broadcom
AVGO
$1.82T
| $2.18M | 0.02% |
126,350
-26,280
| -17% | -$440K |
|
577
Omnicom Group
OMC
$22.7B
| $2.17M | 0.02% |
+25,572
| New | +$2.14M |
|
578
Goldman Sachs
GS
$313B
| $2.17M | 0.02% |
+13,436
| New | +$2.18M |
|
|
BDN
579
Brandywine Realty Trust
BDN
$551M
| $2.16M | 0.02% |
+138,261
| New | +$2.25M |
|
|
CAVM
580
DELISTED
Cavium, Inc.
CAVM
| $2.13M | 0.02% |
36,659
-21,851
| -37% | -$1.09M |
|
581
Timken Company
TKR
$9.82B
| $2.13M | 0.02% |
60,518
-8,044
| -12% | -$265K |
|
582
Mercado Libre
MELI
$91.3B
| $2.12M | 0.02% |
11,456
+6,368
| +125% | +$1.06M |
|
583
Orthofix Medical
OFIX
$455M
| $2.11M | 0.02% |
49,373
-10,250
| -17% | -$457K |
|
584
Helmerich & Payne
HP
$3.53B
| $2.1M | 0.01% |
31,158
+13,089
| +72% | +$821K |
|
585
BJ's Restaurants
BJRI
$1.41B
| $2.09M | 0.01% |
58,906
-326,559
| -85% | -$13.1M |
|
586
Invesco
IVZ
$13.3B
| $2.06M | 0.01% |
65,745
-254,158
| -79% | -$7.47M |
|
587
Lincoln National
LNC
$7.91B
| $2.05M | 0.01% |
43,610
-70,866
| -62% | -$3.17M |
|
|
ETFC
588
DELISTED
E*Trade Financial Corporation
ETFC
| $2.05M | 0.01% |
70,372
+44,923
| +177% | +$1.16M |
|
589
OneMain Financial
OMF
$6.9B
| $2.04M | 0.01% |
65,995
-93,159
| -59% | -$2.68M |
|
|
UTEK
590
DELISTED
Ultratech Inc.
UTEK
| $2.04M | 0.01% |
+88,535
| New | +$2.15M |
|
|
XLNX
591
DELISTED
Xilinx Inc
XLNX
| $2.03M | 0.01% |
37,412
-38,216
| -51% | -$1.96M |
|
592
IDEX
IEX
$16.5B
| $2.03M | 0.01% |
21,674
-6,961
| -24% | -$628K |
|
593
Newmont
NEM
$98.2B
| $2.01M | 0.01% |
+51,216
| New | +$2.12M |
|
594
Vodafone
VOD
$34.9B
| $2.01M | 0.01% |
68,979
-353,447
| -84% | -$10.8M |
|
595
Elevance Health
ELV
$81.9B
| $2.01M | 0.01% |
16,010
-481
| -3% | -$62.1K |
|
596
Euronet Worldwide
EEFT
$3.02B
| $2M | 0.01% |
24,496
+15,296
| +166% | +$1.17M |
|
|
EQC
597
DELISTED
Equity Commonwealth
EQC
| $2M | 0.01% |
+66,329
| New | +$2M |
|
598
Textron
TXT
$16.6B
| $1.98M | 0.01% |
49,863
-8,520
| -15% | -$336K |
|
599
Evolent Health
EVH
$475M
| $1.97M | 0.01% |
+80,099
| New | +$1.87M |
|
600
JetBlue
JBLU
$1.96B
| $1.97M | 0.01% |
114,188
+103,626
| +981% | +$1.77M |
|
Similar funds
Marshall Wace's Q3 2016 Portfolio in Review
As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Marshall Wace deployed $1.47B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.
- Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
- Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
- Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
- Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
- Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.
Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.